{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:52:22Z","timestamp":1793159542868,"version":"4.5.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"UKRI Strength in Places Fund","award":["SIPF00007\/1"],"award-info":[{"award-number":["SIPF00007\/1"]}]},{"DOI":"10.13039\/501100000327","name":"Heart Research UK","doi-asserted-by":"publisher","award":["SCOT24-100004"],"award-info":[{"award-number":["SCOT24-100004"]}],"id":[{"id":"10.13039\/501100000327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/24\/11946"],"award-info":[{"award-number":["PG\/24\/11946"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"British Heart Foundation Centre for Research Excellence Grant","award":["RE\/18\/6\/34217"],"award-info":[{"award-number":["RE\/18\/6\/34217"]}]},{"name":"RS Macdonald Charitable Trust \u2018Seedcorn Funding for Multidisciplinary Stroke Research\u2019","award":["GA-03503"],"award-info":[{"award-number":["GA-03503"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Many patients with cancer develop heart failure (HF), and many patients with HF develop cancer. Inter-relationships between their natural histories are rarely reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Health records were obtained for a Scottish region. People aged &amp;gt;50 years were classified by the presence or absence of HF, loop diuretics (a pharmacological marker of congestion), and cancer. Incident cancer, mortality, and cause of death were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 317 178 people aged &amp;gt;50 years, 11 268 (3.6%) had HF of whom 6276 were prescribed loop diuretics; a further 19 044 (6.0%) received loop diuretics. Thus, 30 312 (9.6%) people met an expanded definition of heart failure (HFexp). Annual cancer incidence was slightly higher for those with HFexp (incidence rate ratio 1.10; P &amp;lt; .001), varying amongst cancer types. For people with neither cancer nor HFexp, mortality was &amp;lt;3% annually; most deaths were cardiovascular. For those with cancer but not HFexp, annual mortality was 6.3% for women and 9.0% for men; most died of cancer. For those with HFexp but not cancer, annual mortality ranged from 6.6% to 18.4% depending on sex and HFexp criteria applied; most deaths were cardiovascular. For those with both cancer and HFexp, annual mortality ranged from 14.5% to 28.4%; cardiovascular and cancer mortality rates were similar. Few patients died at home (\u223c20%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with HFexp have a slightly higher risk of cancer overall, but this may vary according to cancer type. Patients with both cancer and HFexp have a poor prognosis with a similar proportion of deaths attributed to cancer and cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag120","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:45:59Z","timestamp":1770900359000},"page":"3152-3169","source":"Crossref","is-referenced-by-count":4,"title":["Cancer and heart failure: prevalence, incidence, and prognosis in Scotland"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7413-8449","authenticated-orcid":false,"given":"Antonio","family":"Iaconelli","sequence":"first","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow , University Avenue, Glasgow, Scotland G12 8QQ ,","place":["UK"]},{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS , Largo Agostino Gemelli, 8, Rome 00168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9878-8913","authenticated-orcid":false,"given":"Moustafa I","family":"Morsy","sequence":"additional","affiliation":[{"name":"School of Infection & Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1658-3883","authenticated-orcid":false,"given":"Jocelyn M","family":"Friday","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow , University Avenue, Glasgow, Scotland G12 8QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow , University Avenue, Glasgow, Scotland G12 8QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8848-1395","authenticated-orcid":false,"given":"Benjamin M P","family":"Elyan","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow , University Avenue, Glasgow, Scotland G12 8QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8441-6887","authenticated-orcid":false,"given":"Ninian N","family":"Lang","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow , University Avenue, Glasgow, Scotland G12 8QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-7035","authenticated-orcid":false,"given":"Jill P","family":"Pell","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3811-8165","authenticated-orcid":false,"given":"Jim","family":"Lewsey","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-7098","authenticated-orcid":false,"given":"Daniel F","family":"Mackay","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-4286","authenticated-orcid":false,"given":"Ruth","family":"Dundas","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-6432","authenticated-orcid":false,"given":"Tran Q B","family":"Tran","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5195-5312","authenticated-orcid":false,"given":"Denise","family":"Brown","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-9025","authenticated-orcid":false,"given":"Frederick K","family":"Ho","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-3319","authenticated-orcid":false,"given":"Claire E","family":"Hastie","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2185-4502","authenticated-orcid":false,"given":"Michael","family":"Fleming","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia E","family":"Geue","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8728-3730","authenticated-orcid":false,"given":"Alan","family":"Stevenson","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clea","family":"du Toit","sequence":"additional","affiliation":[{"name":"Digital Health Validation Lab, Living Lab, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-5808","authenticated-orcid":false,"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow , University Avenue, Glasgow, Scotland G12 8QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3926-4225","authenticated-orcid":false,"given":"Pasquale","family":"Maffia","sequence":"additional","affiliation":[{"name":"School of Infection & Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II , Naples ,","place":["Italy"]},{"name":"Africa-Europe CoRE in Non-Communicable Diseases & Multimorbidity, African Research Universities Alliance (ARUA) & The Guild of European Research-Intensive Universities , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sensini","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Feccia","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pecorini","sequence":"additional","affiliation":[{"name":"Cardiovascular Internal Medicine Unit, Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK) of German Heart Center Charit\u00e9, German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charit\u00e9 Universit\u00e4tsmedizin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus S","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CBF), German Heart Center Charit\u00e9, BIH Center for Regenerative Therapies (BCRT) & German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, University Medicine Berlin FU and HU , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9404-8846","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[{"name":"Center of Excellence in Cardiovascular Sciences, Ospedale Isola Tiberina, Gemelli Isola Roma , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-7016","authenticated-orcid":false,"given":"John G F","family":"Cleland","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow , University Avenue, Glasgow, Scotland G12 8QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"2026062219563444700_ehag120-B1","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure: a contemporary perspective","volume":"128","author":"Roger","year":"2021","journal-title":"Circ Res"},{"key":"2026062219563444700_ehag120-B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"2026062219563444700_ehag120-B3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jacc.2013.04.088","article-title":"Patients with heart failure have an increased risk of incident cancer","volume":"62","author":"Hasin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563444700_ehag120-B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2715","article-title":"Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers","volume":"25","author":"Shi","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026062219563444700_ehag120-B5","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/ejhf.2029","article-title":"Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"22","author":"de Boer","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026062219563444700_ehag120-B6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ejhf.472","article-title":"Incidence of cancer in patients with chronic heart failure: a long-term follow-up study","volume":"18","author":"Banke","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026062219563444700_ehag120-B7","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/ejhf.2207","article-title":"The association between heart failure and incident cancer in women: an analysis of the Women\u2019s Health Initiative","volume":"23","author":"Leedy","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026062219563444700_ehag120-B8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jacc.2018.01.069","article-title":"Lack of association between heart failure and incident cancer","volume":"71","author":"Selvaraj","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563444700_ehag120-B9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ijcard.2020.10.072","article-title":"Prevalence and incidence of various cancer subtypes in patients with heart failure vs matched controls","volume":"326","author":"Schwartz","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026062219563444700_ehag120-B10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ejhf.1165","article-title":"Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge","volume":"20","author":"Ameri","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026062219563444700_ehag120-B11","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1093\/eurheartj\/ehae34511","article-title":"Loop diuretic utilisation with or without heart failure: impact on prognosis","volume":"45","author":"Friday","year":"2024","journal-title":"Eur Heart J"},{"key":"2026062219563444700_ehag120-B12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"The Lancet"},{"key":"2026062219563444700_ehag120-B13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ejhf.2220","article-title":"Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial","volume":"23","author":"Pellicori","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026062219563444700_ehag120-B14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/ije\/dys188","article-title":"Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)","volume":"41","author":"Denaxas","year":"2012","journal-title":"Int J Epidemiol"},{"key":"2026062219563444700_ehag120-B15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"The Lancet"},{"key":"2026062219563444700_ehag120-B16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026062219563444700_ehag120-B17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2026062219563444700_ehag120-B18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jacc.2016.04.053","article-title":"Heart failure after myocardial infarction is associated with increased risk of cancer","volume":"68","author":"Hasin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563444700_ehag120-B19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/hr.2017.45","article-title":"Does the pathophysiology of heart failure prime the incidence of cancer?","volume":"40","author":"Sakamoto","year":"2017","journal-title":"Hypertens Res"},{"key":"2026062219563444700_ehag120-B20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jjcc.2020.07.026","article-title":"Differential risk of incident cancer in patients with heart failure: a nationwide population-based cohort study","volume":"77","author":"Kwak","year":"2021","journal-title":"J Cardiol"},{"key":"2026062219563444700_ehag120-B21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaccao.2021.11.007","article-title":"Cancer incidence and mortality according to Pre-existing heart failure in a community-based cohort","volume":"4","author":"Bertero","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2026062219563444700_ehag120-B22","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/cvr\/cvz035","article-title":"Common risk factors for heart failure and cancer","volume":"115","author":"Meijers","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2026062219563444700_ehag120-B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","article-title":"Anticancer drug-induced kidney disorders","volume":"24","author":"Kintzel","year":"2001","journal-title":"Drug Saf"},{"key":"2026062219563444700_ehag120-B24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11739-014-1064-9","article-title":"Cardiovascular oncology: a new discipline inside internal medicine?","volume":"9","author":"Prisco","year":"2014","journal-title":"Intern Emerg Med"},{"key":"2026062219563444700_ehag120-B25","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.3748\/wjg.v20.i22.6844","article-title":"Role of the Na+\/K+\/2Cl- cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma","volume":"20","author":"Shiozaki","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2026062219563444700_ehag120-B26","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1186\/s12885-019-6242-8","article-title":"Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Cancer"},{"key":"2026062219563444700_ehag120-B27","doi-asserted-by":"publisher","first-page":"e2697","DOI":"10.1136\/bmj.e2697","article-title":"Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database","volume":"344","author":"Bhaskaran","year":"2012","journal-title":"BMJ"},{"key":"2026062219563444700_ehag120-B28","doi-asserted-by":"publisher","first-page":"k4209","DOI":"10.1136\/bmj.k4209","article-title":"Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study","volume":"363","author":"Hicks","year":"2018","journal-title":"BMJ"},{"key":"2026062219563444700_ehag120-B29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/ph13060105","article-title":"Beta-blockers and cancer: where are we?","volume":"13","author":"Peixoto","year":"2020","journal-title":"Pharmaceuticals"},{"key":"2026062219563444700_ehag120-B30","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1113\/JP276746","article-title":"Mechanisms underlying the cross-talk between heart and cancer","volume":"598","author":"Brancaccio","year":"2020","journal-title":"Journal of Physiology"},{"key":"2026062219563444700_ehag120-B31","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/bjs.9229","article-title":"Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer","volume":"100","author":"De Bruijn","year":"2013","journal-title":"Br J Surg"},{"key":"2026062219563444700_ehag120-B32","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.amjmed.2022.08.012","article-title":"Inflammatory bowel disease and cardiovascular diseases","volume":"135","author":"Chen","year":"2022","journal-title":"Am J Med"},{"key":"2026062219563444700_ehag120-B33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12029-022-00816-0","article-title":"Risk of cancer in inflammatory bowel disease and pitfalls in oncologic therapy","volume":"54","author":"Peixoto","year":"2023","journal-title":"J Gastrointest Cancer"},{"key":"2026062219563444700_ehag120-B34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/art.41979","article-title":"Myocardial dysfunction and heart failure in rheumatoid arthritis","volume":"74","author":"Park","year":"2022","journal-title":"Arthritis and Rheumatology"},{"key":"2026062219563444700_ehag120-B35","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyae006","article-title":"Rheumatoid arthritis and cancer risk in the Million Women Study","volume":"53","author":"Yang","year":"2024","journal-title":"Int J Epidemiol"},{"key":"2026062219563444700_ehag120-B36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/nejmoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026062219563444700_ehag120-B37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1161\/CIRCULATIONAHA.118.033603","article-title":"Linking heart failure to cancer background evidence and research perspectives","volume":"138","author":"Bertero","year":"2018","journal-title":"Circulation"},{"key":"2026062219563444700_ehag120-B38","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816","article-title":"Heart failure stimulates tumor growth by circulating factors","volume":"138","author":"Meijers","year":"2018","journal-title":"Circulation"},{"key":"2026062219563444700_ehag120-B39","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2026062219563444700_ehag120-B40","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/ijc.27339","article-title":"Cigarette smoking and lung cancer\u2014relative risk estimates for the major histological types from a pooled analysis of case\u2014control studies","volume":"131","author":"Pesch","year":"2012","journal-title":"Int J Cancer"},{"key":"2026062219563444700_ehag120-B41","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/bjc.2014.579","article-title":"Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis","volume":"112","author":"Bagnardi","year":"2015","journal-title":"Br J Cancer"},{"key":"2026062219563444700_ehag120-B42","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.15420\/CFR.2024.07","article-title":"Pathophysiology of congestion in heart failure: a contemporary review","volume":"10","author":"Kumric","year":"2024","journal-title":"Card Fail Rev"},{"key":"2026062219563444700_ehag120-B43","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/bcp.13152","article-title":"Spironolactone use and risk of incident cancers: a retrospective, matched cohort study","volume":"83","author":"Mackenzie","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"2026062219563444700_ehag120-B44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/2159-8274.CD-10-0020","article-title":"A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment","volume":"1","author":"Platz","year":"2011","journal-title":"Cancer Discov"},{"key":"2026062219563444700_ehag120-B45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.7326\/0003-4819-158-10-201305210-00005","article-title":"Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer","volume":"158","author":"Daskivich","year":"2013","journal-title":"Ann Intern Med"},{"key":"2026062219563444700_ehag120-B46","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/jamacardio.2019.3593","article-title":"Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86000 individuals","volume":"4","author":"Conrad","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026062219563444700_ehag120-B47","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/ejhf.1569","article-title":"Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise","volume":"21","author":"Moliner","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026062219563444700_ehag120-B48","doi-asserted-by":"publisher","first-page":"e13273","DOI":"10.1111\/eci.13273","article-title":"Cancer in chronic heart failure patients in the GISSI-HF trial","volume":"50","author":"Ameri","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"2026062219563444700_ehag120-B49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/cvr\/cvz198","article-title":"High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death","volume":"116","author":"Pellicori","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2026062219563444700_ehag120-B50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ejhf.1689","article-title":"What do patients with heart failure die from? A single assassin or a conspiracy?","volume":"22","author":"Anker","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026062219563444700_ehag120-B51","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jacc.2024.08.052","article-title":"Adjudication of hospitalizations and deaths in the IRONMAN trial of intravenous iron for heart failure","volume":"84","author":"Cleland","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563444700_ehag120-B52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ejhf.191","article-title":"Fruit and vegetable intake and rate of heart failure: a population-based prospective cohort of women","volume":"17","author":"Rautiainen","year":"2015","journal-title":"Eur J Heart Fail"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/24\/3152\/68202875\/ehag120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/24\/3152\/68202875\/ehag120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:56:38Z","timestamp":1782172598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/24\/3152\/8666517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":52,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2026,5,2]]},"published-print":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag120","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,21]]},"published":{"date-parts":[[2026,5,2]]}}}